Frankly Speaking About Family Medicine

Latest Episodes:

Ask About It: From Symptoms to Treatment for Genitourinary Syndrome of Menopause - Frankly Speaking Ep 510 Nov 09, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-510

Overview: Genitourinary syndrome of menopause (GSM) often goes unreported unless clinicians ask. This episode helps you proactively identify vaginal and urinary symptoms, understand how intravaginal dehydroepiandrosterone (DHEA) works, evaluate evidence supporting its use for vulvovaginal atrophy (VVA), and guide patient-centered treatment discussions that can improve comfort, sexual health, and quality of life.

Episode resource links:

Lemos, M. J., Queiroz, L. F., Diniz, A. F., Longo da Silva, C. M., Dos Santos, P. L., de Oliveira Gomide, P., Ferraz, J. M., & De Marco Novellino, A. M. (2026). Intravaginal dehydroepiandrosterone for the treatment of vulvovaginal atrophy: a systematic review and meta-analysis. Menopause (New York, N.Y.), 33(7), 852–858. https://doi.org/10.1097/GME.0000000000002736

Guest: Jill M. Terrien PhD, ANP-BC
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Picking a Winner: Antibiotic Selection for Sinusitis - Frankly Speaking Ep 509 Nov 02, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-509

Overview: Listen in to sharpen your prescribing confidence when treating acute sinusitis. This episode covers the latest recommendations on when antibiotics are truly indicated, plus the evidence on amoxicillin alone vs amoxicillin-clavulanate—so you can select the right agent, reduce adverse effects, and avoid sacrificing outcomes in uncomplicated cases.

Episode resource links:

Savage TJ, Butler AM, Kronman MP, et al. Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults. JAMA. 2026;335(19):1694-1705.
Payne SC, McKenna M, Buckley J, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngol Head Neck Surg. 2025;173 Suppl 1:S1-S56.

Guest: Alan M. Ehrlich, MD, FAAFP
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Beyond Blood Loss: A Shift in the Leading Causes of Maternal Death - Frankly Speaking Ep 508 Oct 26, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-508

Overview: We’ve long understood cardiovascular disease, hemorrhage, hypertension, and infection as the leading killers of pregnant patients. A recent analysis challenges that, finding the leading causes are now overdose, homicide, and suicide. Join us as we unpack what this means for clinicians, explore racial and age disparities, and discuss how primary care clinicians can better protect maternal health.

Episode resource links:

Identify unintentional drug overdose and violence (homicide and suicide) as the leading causes of maternal death in the United States from 2018–2023, surpassing traditional obstetric complications
Describe racial, ethnic, and age-related disparities in pregnancy-associated mortality due to overdose, homicide, and suicide
Apply an updated, comprehensive approach to screening and counseling pregnant and postpartum patients that incorporates substance use, intimate partner violence, and mental health risk factors

Guest: Mariyan L. Montaque, DNP, FNP-BC
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Substances and Falls in Older Adults: Recognizing Risk, Improving Outcomes - Frankly Speaking Ep 507 Oct 19, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-507

Overview: Falls in older adults can have devastating consequences; substance use and prescription medications are often-overlooked risk factors. Tune in to explore how screening for substance use in a primary care environment may decrease fall and related injury risk in adults over 55. Come away with stronger identification and prevention practices.

Episode resource links:

Babu KM, Haddad YK, Krotulski AJ, Causey ST, Vargas-Torres CC, Martinez PM, Goldberg EM, Dorfman JD, Bailey M, Chapman BP, Graham P, Lai JT, Saif R, Elhoussan R, Capeta Romero A, Londoño-Barreras R, Walton SE, Thomas DD, Logan BK, Merchant RC. Relationship of ethanol, cannabinoids, benzodiazepines, and opioids to serious injuries from falls in adults aged 55 and older. J Emerg Med. 2026;84:46-58. doi:10.1016/j.jemermed.2025.12.017
Colón-Emeric CS, McDermott CL, Lee DS, Berry SD. Risk Assessment and Prevention of Falls in Older Community-Dwelling Adults: A Review. JAMA. 2024;331(16):1397–1406. doi:10.1001/jama.2024.1416
US Preventive Services Task Force. Interventions to Prevent Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2024;332(1):51–57. doi:10.1001/jama.2024.8481

Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

It’s All in the Squeeze: Grip Strength and Mortality in Older Women - Frankly Speaking EP 506 Oct 12, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-506

Overview: Overview copy

Episode resource links:

LaMonte MJ, Hyde ET, Nguyen S, et al. Muscular Strength and Mortality in Women Aged 63 to 99 Years. JAMA Netw Open. 2026;9(2):e2559367. doi:10.1001/jamanetworkopen.2025.59367
Free evidence-based resources for strength training
o Exercise & Physical Activity: Your Everyday Guide from the National Institute on Aging
o Senior_Strength_Training_Workouts.pdf

Guest: Jill M. Terrien PhD, ANP-BC
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

PMOS—Expanding Diagnosis and Care Beyond Cysts and Cycles - Frankly Speaking Ep 505 Oct 05, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-505

Overview: The renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) reflects the true complexity of this diagnosis—a condition that extends beyond ovarian cysts and reproductive health. Listen in as we explore what drove the name change, how it better reflects the condition’s complexity, and what current evidence says about prevalence, risk, and whole-body management strategies for your patients.

Episode resource links:

Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S., Joham, A. E., Costello, M. F., ... & Piltonen, T. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet.
Tewari, S., Khalua, R. K., & Parida, S. (2026). Redefining polycystic ovary syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS): implications for diagnosis, pathophysiology and clinical management. Int J Gynaecol Sci, 8(1), 17-25.
Tewari, S., Pramanik, P., Patra, T., & MK, M. (2026). From Reproductive Disorder to Metabolic Syndrome: The Evolution of Polycystic Ovary Syndrome (PCOS) into Polyendocrine Metabolic Ovarian Syndrome (PMOS). Journal of Pharmacognosy and Phytochemistry, 15(3), 329-337.

Guest: Mariyan L. Montaque, DNP, FNP-BC
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Lowering the Pressure: Hypertension Guidelines Interpreted - Frankly Speaking Ep 504 Sep 28, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-504

Overview: In this episode, we discuss the American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guidelines, explore where the evidence may support or challenge recommendations, and provide practical frameworks for implementing lifestyle interventions to improve the outcomes of hypertension care.

Episode resource links:

Guest: Robert A. Baldor MD, FAAFP

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

The Nutrition Prescription: Can Legumes and Soy Lower Hypertension Risk? - Frankly Speaking Ep 503 Sep 21, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-503

Overview: In this episode, we discuss how prescribing “food as medicine” can complement hypertension management in primary care. We review the evidence supporting legumes, soy, and DASH-based nutrition for lowering blood pressure, while providing practical counseling strategies to help patients adopt dietary patterns that enhance cardiovascular health alongside standard medical therapy.

Episode resource links:

Metoudi M, et al. bmjnph 2026;0:e001449. doi:10.1136/bmjnph-2025-001449
Brindal E, Baird D. Regular Flatulence Patterns Among Community-Dwelling Individuals in Australia. JAMA Netw Open. 2026;9(5):e2615637. doi:10.1001/jamanetworkopen.2026.15637
DASH - DASH Eating Plan | NHLBI, NIH

Guest: Robert A. Baldor MD, FAAFP

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Abdominal Obesity and Menopausal Symptoms: Recognizing the Connection, Personalizing Care - Frankly Speaking Ep 502 Sep 14, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-502

Overview: Abdominal obesity can influence both the severity of menopausal symptoms and treatment decisions. Listen in as we discuss how to recognize this important relationship, apply practical screening tools, and individualize menopause management to improve symptom control and overall health outcomes for your patients.

Episode resource links:

Wang, D. , Wang, F. , Zheng, J. , Chen, X. , Lei, Y. & Su, J. (9900). Menopausal symptom network differences between women with and without waist-to-height ratio-defined abdominal obesity. Menopause, Publish Ahead of Print , doi: 10.1097/GME.0000000000002794.
Managing Menopausal Symptoms: Common Questions and Answers.
Chang JG, Lewis MN, Wertz MC. American Family Physician. 2023;108(1):28-39.

Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Leucovorin for Autism Spectrum Disorder: Is There Any Evidence Behind the Hype? - Frankly Speaking Ep 501 Sep 07, 2026

Show notes

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-501

Overview: Leucovorin has gained growing attention as a treatment for autism spectrum disorder (ASD), despite limited supporting evidence. In this episode, we discuss the rationale behind its use, review the current literature, and examine the American Academy of Pediatrics’ guidance on this treatment for ASD, giving you confidence to counsel families and engage in meaningful shared decision-making.

Episode resource links:

Discuss the rationale for using leucovorin in treatment of autism spectrum disorder (ASD)
Review current evidence and practice guidelines regarding leucovorin and ASD
Examine data and recent national trends in prescription rates of leucovorin for ASD

Guest: Anne Powell, MD
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.